136 related articles for article (PubMed ID: 26735499)
1. Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer.
Halabi NM; Martinez A; Al-Farsi H; Mery E; Puydenus L; Pujol P; Khalak HG; McLurcan C; Ferron G; Querleu D; Al-Azwani I; Al-Dous E; Mohamoud YA; Malek JA; Rafii A
PLoS Genet; 2016 Jan; 12(1):e1005755. PubMed ID: 26735499
[TBL] [Abstract][Full Text] [Related]
2. Systematic pan-cancer analysis of somatic allele frequency.
Spurr L; Li M; Alomran N; Zhang Q; Restrepo P; Movassagh M; Trenkov C; Tunnessen N; Apanasovich T; Crandall KA; Edwards N; Horvath A
Sci Rep; 2018 May; 8(1):7735. PubMed ID: 29769535
[TBL] [Abstract][Full Text] [Related]
3. High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer.
Tan IB; Malik S; Ramnarayanan K; McPherson JR; Ho DL; Suzuki Y; Ng SB; Yan S; Lim KH; Koh D; Hoe CM; Chan CY; Ten R; Goh BK; Chung AY; Tan J; Chan CX; Tay ST; Alexander L; Nagarajan N; Hillmer AM; Tang CL; Chua C; Teh BT; Rozen S; Tan P
Genome Biol; 2015 Feb; 16(1):32. PubMed ID: 25808843
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed somatic alleles are enriched in functional elements in Breast Cancer.
Restrepo P; Movassagh M; Alomran N; Miller C; Li M; Trenkov C; Manchev Y; Bahl S; Warnken S; Spurr L; Apanasovich T; Crandall K; Edwards N; Horvath A
Sci Rep; 2017 Aug; 7(1):8287. PubMed ID: 28811643
[TBL] [Abstract][Full Text] [Related]
5. SNVSniffer: an integrated caller for germline and somatic single-nucleotide and indel mutations.
Liu Y; Loewer M; Aluru S; Schmidt B
BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):47. PubMed ID: 27489955
[TBL] [Abstract][Full Text] [Related]
6. Verifying the markers of ovarian cancer using RNA-seq data.
Liu T; Yu N; Ding F; Wang S; Li S; Zhang X; Sun X; Chen Y; Liu P
Mol Med Rep; 2015 Jul; 12(1):1125-30. PubMed ID: 25776533
[TBL] [Abstract][Full Text] [Related]
7. Marked allelic imbalance on chromosome 5q31 does not explain alpha-catenin expression in epithelial ovarian cancer.
Tuhkanen H; Anttila M; Kosma VM; Puolakka J; Juhola M; Heinonen S; Mannermaa A
Gynecol Oncol; 2004 Aug; 94(2):416-21. PubMed ID: 15297182
[TBL] [Abstract][Full Text] [Related]
8. A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.
Reinartz S; Finkernagel F; Adhikary T; Rohnalter V; Schumann T; Schober Y; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Müller-Brüsselbach S; Müller R
Genome Biol; 2016 May; 17(1):108. PubMed ID: 27215396
[TBL] [Abstract][Full Text] [Related]
9. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression identifies subgroups of ovarian carcinoma.
Skubitz AP; Pambuccian SE; Argenta PA; Skubitz KM
Transl Res; 2006 Nov; 148(5):223-48. PubMed ID: 17145569
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
12. Identification of genes associated with ovarian cancer metastasis using microarray expression analysis.
Lancaster JM; Dressman HK; Clarke JP; Sayer RA; Martino MA; Cragun JM; Henriott AH; Gray J; Sutphen R; Elahi A; Whitaker RS; West M; Marks JR; Nevins JR; Berchuck A
Int J Gynecol Cancer; 2006; 16(5):1733-45. PubMed ID: 17009964
[TBL] [Abstract][Full Text] [Related]
13. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
14. Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis.
LaFramboise T; Dewal N; Wilkins K; Pe'er I; Freedman ML
PLoS Genet; 2010 Sep; 6(9):e1001086. PubMed ID: 20824129
[TBL] [Abstract][Full Text] [Related]
15. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Fleck JL; Pavel AB; Cassandras CG
BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
[TBL] [Abstract][Full Text] [Related]
16. FGMD: A novel approach for functional gene module detection in cancer.
Jin D; Lee H
PLoS One; 2017; 12(12):e0188900. PubMed ID: 29244808
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of recurrent properties of cancer genes to identify novel drivers.
D'Antonio M; Ciccarelli FD
Genome Biol; 2013 May; 14(5):R52. PubMed ID: 23718799
[TBL] [Abstract][Full Text] [Related]
18. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.
van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E
Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173
[TBL] [Abstract][Full Text] [Related]
19. Analyzing allele specific RNA expression using mixture models.
Lu R; Smith RM; Seweryn M; Wang D; Hartmann K; Webb A; Sadee W; Rempala GA
BMC Genomics; 2015 Aug; 16(1):566. PubMed ID: 26231172
[TBL] [Abstract][Full Text] [Related]
20. A method to reduce ancestry related germline false positives in tumor only somatic variant calling.
Halperin RF; Carpten JD; Manojlovic Z; Aldrich J; Keats J; Byron S; Liang WS; Russell M; Enriquez D; Claasen A; Cherni I; Awuah B; Oppong J; Wicha MS; Newman LA; Jaigge E; Kim S; Craig DW
BMC Med Genomics; 2017 Oct; 10(1):61. PubMed ID: 29052513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
